Major Adverse Liver Outcomes With Tirzepatide and Injectable Semaglutide in Adults With Overweight or Obesity and Type 2 Diabetes [0.03%]
tirzep特肽和可注射司美格鲁肽在超重或肥胖且患有2型糖尿病的成人中出现严重不良肝结局的风险
Mainak Banerjee,Ajitesh Roy,Vivek Mohan Sharma et al.
Mainak Banerjee et al.
Objective: This study aimed to compare the effectiveness of tirzepatide versus injectable semaglutide in preventing major adverse liver outcomes (MALO) among adults with overweight or obesity and type 2 diabetes. ...
Multidimensional Analysis of Early Adiposity Rebound Determinants in Children: Two Key "1000 Days" [0.03%]
儿童早期体重反弹决定因素的多维度分析：两个关键的“1000天”时期
Ling Luo,Xing Wang,Juan Tong et al.
Ling Luo et al.
Objective: Adiposity rebound (AR), the second rise in BMI during growth, increases the risk of obesity and metabolic diseases when it occurs early. We aimed to identify key factors influencing early AR (EAR) within two cr...
Prepregnancy GLP-1 Receptor Agonist Use: Unaccounted Pretreatment BMI May Distort Obstetric Outcome Signals in Real-World Studies [0.03%]
妊娠前GLP-1受体激动剂的使用：未调整的孕前BMI可能会歪曲真实世界研究中的产科结局信号
Mainak Banerjee,Sulagna Dutta,Sujoy Dasgupta
Mainak Banerjee
Early-Life Dietary Protein Source Reshapes Gut Microbiota but Fails to Curtail Diet-Induced Metabolic Syndrome in Young Rats [0.03%]
生命早期膳食蛋白质来源重塑肠道菌群但无法遏制年轻大鼠饮食诱导的代谢综合征发生发展
Chunlong Mu,Micaela Hartslief,Jessica Chong et al.
Chunlong Mu et al.
Objective: Dairy consumption plays a protective role in obesity that may be mediated through the gut microbiota. This study examined the role of dairy proteins, casein, whey, and complete dairy (skim milk powder), and a p...
Perceived Competence and GLP-1RA Weight Management Engagement: Mixed-Methods Insights From Six Patient Groups [0.03%]
GLP-1受体激动剂体重管理动机及参与度：六种患者群体的混合研究方法见解
Jane A McElroy,Isabella Bertarelli,Chloe Maltagliati et al.
Jane A McElroy et al.
Objective: This study aimed to explore patients' perspectives on GLP-1 receptor agonists (GLP-1RAs) for weight loss across the continuum of contemplating use to discontinuation, with and without achieving weight loss goal...
Microdosing Tirzepatide in Multi-Dose Pens: Clinical Individualization, Safety, and Evidence Gaps [0.03%]
微量注射 tirzepatide 预填充笔：临床个体化、安全性和证据缺口
Fernando Vidal-Ostos De Lara
Fernando Vidal-Ostos De Lara
Eating Behavior Latent Profiles and Their Associations With Body Composition in Early Childhood: The CORALS Cohort [0.03%]
《儿童早期进食行为潜在轮廓及其与体成分的关系：基于CORALS队列的研究》
Andrea Jimeno-Martínez,María L Miguel-Berges,Ivie Maneschy et al.
Andrea Jimeno-Martínez et al.
Objective: This study aimed to identify sex-specific eating behavior profiles and assess the associations between eating behaviors subscales and profiles and body composition indices in Spanish preschoolers from the CORAL...
Early Pregnancy Body Roundness Index and Development of Adverse Pregnancy Outcomes: A Secondary Analysis of the nuMoM2b Study [0.03%]
妊娠早期体圆指数与不良妊娠结局的关系：来自nuMoM2b研究的次级分析结果
Kelsey J Pape,Taylor M Bynarowicz,Sruthi Bhamidipalli et al.
Kelsey J Pape et al.
Objective: This study assessed the association between early pregnancy body roundness index (BRI) and adverse pregnancy outcomes in nulliparas. Methods: ...
Hepatic FMO3 Downregulation Contributes to the Metabolic Benefits of Vertical Sleeve Gastrectomy [0.03%]
肝FMO3下调对垂直袖状胃切除术代谢益处的贡献
Hai Yan,Chong Cao,Xiaozhuo Tan et al.
Hai Yan et al.
Objective: Metabolic bariatric surgery, such as vertical sleeve gastrectomy (VSG), is the most effective treatment for obesity, yet the molecular mechanisms remain incompletely defined. This study aims to explore the role...
Patient Characteristics and Engagement in CGM-Supported Virtual Weight Management [0.03%]
基于动态血糖监测的远程体重管理患者的特征及依从性研究
Chen Zheng,Jiage Niu,Yingying Xu
Chen Zheng